Side-by-side comparison of AI visibility scores, market position, and capabilities
Richardson TX North America HVACR manufacturer (NYSE: LII, S&P 500 Dec 2024) at $5.3B 2024 revenue (+16.47%); 14,200 employees with residential dealer network competing with Carrier and Trane for US HVAC replacement market.
Lennox International Inc. is a Richardson, Texas-based manufacturer and marketer of heating, ventilation, air conditioning, and refrigeration (HVACR) products — publicly traded on the New York Stock Exchange (NYSE: LII) as an S&P 500 component (added December 2024) — generating $5.3 billion in revenue for fiscal 2024 (+16.47% year-over-year) with approximately 14,200 employees. The company operates through two primary segments: Residential HVAC (67% of 2024 sales, selling under Lennox, Armstrong Air, Allied, AirEase, Ducane, and Concord brands through dealer networks) and Commercial HVAC and Refrigeration (33% of sales, including Heatcraft commercial refrigeration through Bohn and Larkin brands). In late 2023, Lennox completed the strategic sale of its European HVAC and refrigeration businesses to focus exclusively on North America. CEO Alok Maskara has led the company since May 2022. The company traces its roots to 1895 when Dave Lennox accepted the patent for a riveted steel coal furnace in Marshalltown, Iowa.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.